Nevertheless, an increase in contrast of the primary tumor, in lymph node metastases, as well as in bone metastases of the PCa of a late acquisition compared to an earlier acquisition could be shown for all different PSMA tracers. Here, FOLH1 is linked to metastatic malignant neoplasm in the lymph nodes.